RE: RE: Read It Carefully Nexvas, I agree with you 100%. I didn't interpret the press release as revealing anything other than ASSURE dosing is completed. What I find hard to believe is that it will take until the end of June for the topline data to be ready to be released. This trial has been going on for so long now and most were done with dosing and received their final IVUS scan weeks if not months ago.
Really, end of June. I don't believe it. If I'm wrong, we'll be waiting until end of June. But humor me for a bit. Look at these two presentations scheduled for beginning of June:
.
May 30 to June 2
National Lipid Association, Las Vegas
https://www.lipid.org/sessions
5/31/13 at 4:50−5:10 PM Transcriptional Regulation of the ApoA-1 Promoter
Norman C.W.Wong,MD, FRCP(C)
.
June 4, European Atherosclerosis Society
Therapeutic options to induce regression of coronary atherosclerosis
Speaker: Steven Nissen
.
Seems like the perfect opportunity for Dr. Wong to present SUSTAIN/ASSURE values for RVX-208 raising apoAI, and HDL-cholesterol. Followed a few days later by Dr. Nissen presenting the Cleveland Clinic's RVX-208 IVUS results.
We will see. GLTA